Aerovate Therapeutics Inc
NASDAQ:AVTE
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.41
30.75
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
AVTE Price Targets Summary
Aerovate Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AVTE is 2.38 USD with a low forecast of 2.02 USD and a high forecast of 3.15 USD.
AVTE Last Price Targets
Aerovate Therapeutics Inc
The latest public price target was made on Jun 17, 2024 by Liisa Bayko from Evercore ISI , who expects AVTE stock to drop by 25% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Analyst | Price Target | Date | Article |
---|---|---|---|
Liisa Bayko
Evercore ISI
|
2
USD
Downside 25% |
5 months ago
Jun 17, 2024
|
Aerovate Therapeutics downgraded to In Line from Outperform at Evercore ISI
TheFly
|
Eun Yang
Jefferies
|
2
USD
Downside 25% |
5 months ago
Jun 17, 2024
|
Jefferies Downgrades Aerovate Therapeutics Inc (AVTE) to Hold
StreetInsider
|
Tiago Fauth
Wells Fargo
|
35
USD
Upside 1 216% |
7 months ago
Apr 1, 2024
|
Wells Fargo Adds Aerovate Therapeutics Inc (AVTE) to Q2 '24 Tactical Ideas List
StreetInsider
|
Eun Yang
Jefferies
|
65
USD
Upside 2 344% |
7 months ago
Mar 25, 2024
|
Aerovate Therapeutics Inc (AVTE) PT Raised to $65 at Jefferies, 'valuation does not suggest data needs to be better than sotatercept'
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AVTE's stock price target?
Price Target
2.38
USD
According to Wall Street analysts, the average 1-year price target for AVTE is 2.38 USD with a low forecast of 2.02 USD and a high forecast of 3.15 USD.